Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity-MedSci.cn

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of CXCL9 synergizes with IL-12 gene therapy (TAVO) to elicit robust anti-tumor immunity

Mukhopadhyay, A; Nguyen, B; Lee, JY; Han, M; Salazar, J; Hermiz, R; Svenson, L; Browning, E; O'Connor, DJ; Canton, DA; Fisher, D; Skitzki, J; Twitty, CG

CANCER RESEARCH, 2020; 80 (16):

科室
- - 订阅+
  - 更多科室
工具
服务